Day Trade Cheat Sheet - August 13, 2026 (EOD)

 ## TODAY'S GRADE: B A generally positive trading day with strong sector-specific rallies, especially in AI-related and industrial stocks, though some high-profile tech names and consumer discretionary stocks showed weakness. ## HOW INDEXES TRADED **SPY:** +0.3% - trending higher with moderate strength **QQQ:** +0.5% - led by tech and AI optimism, steady uptrend **IWM:** +0.7% - outperformed with small caps benefiting from industrial gains ## BIGGEST MOVERS ### Winners **$FGI** +216.1% - surged on strong Q2 earnings and low market cap, attracting speculative interest **$LNVGY** +19% - Lenovo shares rallied after reporting record Q1 revenue with AI demand driving optimism **$MAERSK** +8% - shares jumped following strong Q2 profit beat and raised outlook ### Losers **$AAPL** -5% - dropped after earnings, raising concerns about memory chip pricing and margin pressures **$CSCO** - data not available but noted weakness on margin concerns in pre-market **$STUB** - data not available but noted downward pressure due to revenue deceleration concerns ## WHAT WORKED Patterns or setups that worked today: - Earnings gap and go setups in small-cap industrials like **$FGI** and shipping stocks such as **$MAERSK** - Momentum continuation in AI-related tech names, exemplified by **$LNVGY** and Nvidia-related plays - Small cap strength in the Russell 2000, reflecting rotation into growth and cyclical sectors ## WHAT FAILED Setups that didn't work: - Big tech post-earnings fade, notably **$AAPL**, where initial strength gave way to profit-taking amid margin concerns - Consumer discretionary stocks with whale alert activity showed choppy action, failing to sustain early gains - Pre-market weakness in semiconductor-related names like **$CSCO** due to cautious guidance ## AFTER-HOURS WATCH Earnings or news to monitor tonight: - **$INO** - Jefferies upgraded Inovio Pharmaceuticals to Buy with a raised price target, watch for reaction - **$STUB** - Continued focus on revenue deceleration and guidance updates after earnings miss - **$LLY** - Eli Lilly under investor scrutiny after recent swing trader sell signals despite solid fundamentals ## TOMORROW PREVIEW **Early Watch:** **$FGI**, **$LNVGY**, **$MAERSK**, **$INO** **Catalyst:** Continued earnings flow, inflation data, and Fed commentary expected to influence market tone **Bias:** Bullish into tomorrow, supported by strong earnings beats and AI sector momentum, tempered by caution in big tech and consumer discretionary sectors